Live feed
Filing
SC 13G/A
SC 13G/A0000902664-23-001689·Avoro Capital Advisors LLC
Schedule 13G ownership disclosure
Monte Rosa Therapeutics Inc
Security class unavailable · CUSIP: 61225M102
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,325,000
- Percent of class
- 8.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-001689
- Form type
- SC 13G/A
- Filer
- Avoro Capital Advisors LLC
- CIK
- CIK 1633313
- Filed
- Feb 14, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership